DOLE vs SFM

For growth investors, Sprouts Farmers Market, Inc.

(SFM) is the stronger pick with 14. 1% revenue growth year-over-year, versus 8. 2% for Dole plc (DOLE). Sprouts Farmers Market, Inc. (SFM) offers the better valuation at 14. 7x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Dole plc (DOLE) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Sprouts Farmers Market, Inc.

(SFM) is the cheapest at 14. 7x versus Dole plc at 28. 1x. On forward P/E, Dole plc is actually cheaper at 10. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Sprouts Farmers Market, Inc.

(SFM) delivered a total return of +196. 8%, compared to +12. 9% for Dole plc (DOLE). Over 10 years, the gap is even starker: SFM returned +198. 6% versus DOLE's +12. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Dole plc (DOLE) is the lower-risk stock at 0.

11β versus Sprouts Farmers Market, Inc. 's 0. 17β — meaning SFM is approximately 55% more volatile than DOLE relative to the S&P 500.

By revenue growth (latest reported year), Sprouts Farmers Market, Inc.

(SFM) is pulling ahead at 14. 1% versus 8. 2% for Dole plc (DOLE). On earnings-per-share growth, the picture is similar: Sprouts Farmers Market, Inc. grew EPS 41. 6% year-over-year, compared to -59. 5% for Dole plc. Over a 3-year CAGR, SFM leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sprouts Farmers Market, Inc.

(SFM) is the more profitable company, earning 5. 9% net margin versus 0. 6% for Dole plc — meaning it keeps 5. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SFM leads at 7. 8% versus 2. 4% for DOLE. At the gross margin level — before operating expenses — SFM leads at 37. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Dole plc (DOLE) trades at 10.

8x forward P/E versus 14. 0x for Sprouts Farmers Market, Inc. — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SFM: 16. 3% to $91. 00.

In this comparison, DOLE (2.

2% yield) pays a dividend. SFM does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Dole plc (DOLE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

11), 2. 2% yield). Both have compounded well over 10 years (DOLE: +12. 9%, SFM: +198. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DOLE is a small-cap quality compounder stock; SFM is a small-cap deep-value stock. DOLE pays a dividend while SFM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.